Carol T Mei, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 890 Sunset Dr Ste A-2a, Hollister, CA 95023 Phone: 781-340-0735 Fax: 781-331-6355 |
News Archive
Optimer Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Optimer reported a net loss for the third quarter of 2010 of $11.8 million, or $0.30 per share, which was in line with the Company's expectations. This compares to a net loss for the third quarter of 2009 of $9.4 million, or $0.28 per share. The increase in net loss was primarily due to an increase in research and development and marketing expenses.
DePuy Synthes Spine announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its EXPEDIUM®, VIPER®, and VIPER®2 Spine Systems on patients with adolescent idiopathic scoliosis (AIS), an abnormal curvature of the spine that typically affects children between the ages of 10 and 18.(1) This expands the scoliosis indication for the pedicle screw systems, which now are indicated for both adolescents and adults.
In three separate articles, IRIN reports on the implications of flooding taking place in Africa. "Tens of thousands of people have been affected by flooding in parts of central, eastern and southern Chad following heavy rains in August," the news service writes in the first article, adding that the floods have affected 445,725 people and destroyed 255,720 hectares of cropland.
An intensive, comprehensive, long-term secondary prevention program lasting up to three years after cardiac rehabilitation appears to reduce the risk of a second non-fatal heart attack and other cardiovascular events, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.
› Verified 4 days ago